Sort
172,184 grants matching “inflammation”
HDL Function in Human Disease
$2,571,584Macrae F Linton · Vanderbilt University Medical Center · P01 · FY2023 · HL
Inflammation and Repair in Cardiac Ischemia-Reperfusion
$2,570,374Lewis C Becker · Johns Hopkins University · P01 · FY2010 · HL
Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes
$2,570,283Zeljko Vujaskovic · University Of Maryland Baltimore · U19 · FY2020 · AI
The Role of the Gut Microbiota in Ulcerative Colitis
$2,570,040Vincent B Young · University Of Michigan At Ann Arbor · UH3 · FY2012 · DK
MACS/WIHS -CCS
$2,569,967Maria Luisa Alcaide · University Of Miami School Of Medicine · U01 · FY2023 · HL
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab
$2,569,903Joren C Madsen · Massachusetts General Hospital · U01 · FY2019 · AI
Molecular and Cellular Determinants of Disease Heterogeneity in COPD
$2,569,890Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · HL
Program Project: Role of Innate Immunity in Atherosclerosis
$2,569,768Joseph L Witztum · University Of California, San Diego · P01 · FY2009 · HL
Program Project: Role of Innate Immunity in Atherosclerosis
$2,569,768Joseph L Witztum · University Of California, San Diego · P01 · FY2011 · HL
Program Project: Role of Innate Immunity in Atherosclerosis
$2,569,768Joseph L Witztum · University Of California, San Diego · P01 · FY2010 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2025 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2023 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2022 · HL
Clinical Evaluation of PET Radiotracers
$2,566,871Robert Innis · National Institute Of Mental Health · ZIA · FY2023 · MH
Strategies to Improve Long Term Islet Graft Survival
$2,566,378Camillo Ricordi · University Of Miami School Of Medicine · U01 · FY2006 · DK
Carbohydrate-based Therapy for Lung Disease
$2,565,954John V Fahy · University Of California, San Francisco · P01 · FY2018 · HL
Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3
$2,564,145Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
$2,563,941Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2025 · HL
Structural and Functional Characterization of the Ebola Virus Replication Complex
$2,563,154Gaya K. Amarasinghe · Washington University · P01 · FY2019 · AI
Vascular remodeling in patients with rare genetic disorders
$2,562,680Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Center for Lung Biology and Disease
$2,562,231Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2019 · GM
Clinical Evaluation of PET Radiotracers
$2,562,123Robert Innis · National Institute Of Mental Health · Z01 · FY2008 · MH
Cellular models of fetal neurodevelopment in maternal SARS-CoV-2 infection
$2,560,905Andrea Goldberg Edlow · Massachusetts General Hospital · RF1 · FY2022 · MH
Metabolic Syndrome, Inflammation and Vascular Remodeling
$2,560,516Francine K Welty · Beth Israel Deaconess Medical Center · P50 · FY2007 · HL
HDL Function in Human Disease
$2,559,390Macrae F Linton · Vanderbilt University Medical Center · P01 · FY2025 · HL